What question did this study set out to answer?

The aim is to optimize ethambutol dosing in children undergoing treatment for tuberculosis.

April 1, 2026Open Access

Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-line Antituberculosis Therapy: An Individual Patient Data Meta-Analysis

Key Points

The aim is to optimize ethambutol dosing in children undergoing treatment for tuberculosis.
Conducted an individual patient data meta-analysis
Included various studies on ethambutol in children
Analyzed dosing across different pediatric weight bands
Considered drug exposure and toxicity issues
Findings support revised dosing guidelines for ethambutol
Ensures adequate drug exposure for all weight groups
Addresses formulation and adherence challenges

Abstract

Our IPDMA supports the revision of current pediatric EMB dosing guidelines for the treatment of tuberculosis. Our findings aim to ensure adequate drug exposure across all pediatric weight bands, while also accounting for toxicity and challenges related to formulation implementation and adherence.

Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-line Antituberculosis Therapy: An Individual Patient Data Meta-Analysis

Key Points

Abstract

Cite This Study

Also Consider

Also Consider